about
Kynurenines in CNS disease: regulation by inflammatory cytokinesComputational neuropsychiatry - schizophrenia as a cognitive brain network disorderIn Sickness and in Health: Perineuronal Nets and Synaptic Plasticity in Psychiatric DisordersNMDA receptor modulators: an updated patent review (2013-2014)Synchronizing theta oscillations with direct-current stimulation strengthens adaptive control in the human brainKnockout of NMDA-receptors from parvalbumin interneurons sensitizes to schizophrenia-related deficits induced by MK-801Spatial and temporal boundaries of NMDA receptor hypofunction leading to schizophrenia.Social Stress and Psychosis Risk: Common Neurochemical Substrates?Effects of NMDA and GABA-A Receptor Antagonism on Auditory Steady-State Synchronization in Awake Behaving RatsMetaphor in psychosis: on the possible convergence of Lacanian theory and neuro-scientific researchDeletion of striatal adenosine A(2A) receptor spares latent inhibition and prepulse inhibition but impairs active avoidance learningCognitive and neuroplasticity mechanisms by which congenital or early blindness may confer a protective effect against schizophrenia.A role for D-aspartate oxidase in schizophrenia and in schizophrenia-related symptoms induced by phencyclidine in miceA negative feedback loop controls NMDA receptor function in cortical interneurons via neuregulin 2/ErbB4 signalling.Partial mGlu₅ Negative Allosteric Modulators Attenuate Cocaine-Mediated Behaviors and Lack Psychotomimetic-Like Effects.Exome Sequence Data From Multigenerational Families Implicate AMPA Receptor Trafficking in Neurocognitive Impairment and Schizophrenia Risk.Inhibition of STEP61 ameliorates deficits in mouse and hiPSC-based schizophrenia models.Decreased free d-aspartate levels are linked to enhanced d-aspartate oxidase activity in the dorsolateral prefrontal cortex of schizophrenia patientsAn Integrative Perspective on the Role of Dopamine in SchizophreniaFree D-aspartate regulates neuronal dendritic morphology, synaptic plasticity, gray matter volume and brain activity in mammalsGlycine transporters as novel therapeutic targets in schizophrenia, alcohol dependence and pain.Ketamine and phencyclidine: the good, the bad and the unexpected.Altered functional connectivity links in neuroleptic-naïve and neuroleptic-treated patients with schizophrenia, and their relation to symptoms including volition.Global biochemical profiling identifies β-hydroxypyruvate as a potential mediator of type 2 diabetes in mice and humans.Frontal P3 event-related potential is related to brain glutamine/glutamate ratio measured in vivo.Ionotropic GABA and Glutamate Receptor Mutations and Human Neurologic Diseases.Anti-N-methyl-d-aspartate receptor encephalitis in a patient with a 7-year history of being diagnosed as schizophrenia: complexities in diagnosis and treatmentHaplotypes of the D-Amino Acid Oxidase Gene Are Significantly Associated with Schizophrenia and Its Neurocognitive Deficits.d-amino acid oxidase knockout (Dao(-/-) ) mice show enhanced short-term memory performance and heightened anxiety, but no sleep or circadian rhythm disruption.Reciprocal Alterations in Regulator of G Protein Signaling 4 and microRNA16 in SchizophreniaAltered Hub Functioning and Compensatory Activations in the Connectome: A Meta-Analysis of Functional Neuroimaging Studies in SchizophreniaNeurological dysfunctions associated with altered BACE1-dependent Neuregulin-1 signaling.Synthesis and structure activity relationship of tetrahydroisoquinoline-based potentiators of GluN2C and GluN2D containing N-methyl-D-aspartate receptorsSearching for cognitive enhancement in the Morris water maze: better and worse performance in D-amino acid oxidase knockout (Dao(-/-)) mice.From gut dysbiosis to altered brain function and mental illness: mechanisms and pathwaysReduced cortical expression of a newly identified splicing variant of the DLG1 gene in patients with early-onset schizophreniaEffects of ketamine on context-processing performance in monkeys: a new animal model of cognitive deficits in schizophreniaBalanced translocation linked to psychiatric disorder, glutamate, and cortical structure/function.Heteromeric dopamine receptor signaling complexes: emerging neurobiology and disease relevanceDynamic brain network reconfiguration as a potential schizophrenia genetic risk mechanism modulated by NMDA receptor function.
P2860
Q21129356-0CB9B85B-6B6C-447F-8E47-8C279D40DD97Q22241226-2821205D-F6E1-4957-9C32-788B4281CF85Q26769948-9845FD09-419C-4883-B412-2F29C7E7A722Q26997407-F2F6E7F5-2A63-4F4F-9AB9-907E4B792DACQ27323969-95E44314-62A8-4AFD-8203-1015F42C640CQ27338525-4343C171-365D-4B0E-89F3-27EB11EE28D0Q30355619-07195E9E-062E-4D23-AA2F-5D07F29DE513Q30364687-B8016A7E-FB4B-473E-A2A4-281B5D47263BQ30403781-61ED8CDF-4867-47EB-B05A-52E87C8EAD7AQ30409000-729A2C0D-A5AA-4045-AF0C-8C9FC7822565Q30440698-C7FF62A7-6E95-4B7C-8101-D8543A9AC4D1Q30458900-B4B4A25E-E867-4E0D-B0D9-5A8493C7207DQ30651885-6B7001C8-8212-4DCA-BFE9-8812CC7B6889Q30652639-A5553AE3-4891-4234-B421-324C07DD7B7AQ30709836-57972020-0413-4A18-B5CD-BDFE1647B1DBQ30997126-B1E06A85-08F9-4BF7-A9D6-F86875C9DB0EQ33574936-9618869F-6FAC-4B64-A86D-909EB70E393EQ33718794-EDBC6756-4BA1-445D-8F26-A5DE5A18ECE0Q33839379-7F46C469-CCDF-4F8A-A07D-733D5105C48DQ33990671-CC2C797B-A45E-41A9-8039-D8E68EB0B2FAQ34381226-8559E954-615B-4BA8-A2A4-DA8000F8A2A3Q34480719-967C1537-8F77-40C9-9AF8-309A56EE0AC7Q34484352-F7B97F6F-BCBD-4653-82CC-F5DBC63CECCAQ35220587-8EF32A2F-7A81-469B-A44D-F2E8A5AD14E1Q35374474-DA3ADC9D-8C5C-4771-8D58-6082F8DCA05DQ35745930-DAFEBD14-EA6A-433F-8907-9502A1E1B15EQ35746924-2C540D12-32AB-408E-ABAA-850CF94E3247Q35961065-4AFFD556-8587-47B9-8211-B46DF45ED413Q36554272-E30B2DF7-C0B3-4163-A08F-4B4A2D75988AQ36580028-FADFD452-C96A-414C-AF56-9E5B4AACFEB6Q36580042-901277E0-EF85-43EC-8D0C-E9C12ED650F4Q36804007-32276991-23EE-4A30-B5E0-C9C5779EBA50Q36851341-68537268-FB2F-4E44-BBDB-B444CEE7C950Q36866353-49F6BD3F-8505-4245-8A8C-08C788ADDAECQ36932850-B583E4E0-410B-4EB7-A3A6-9AE225D227C7Q37058642-52CC9230-BE42-4C70-86DB-9287D25B0CA7Q37172725-1B5DA7D3-8021-4E1F-9F8C-B081C1DD41C8Q37195865-7EBCEA4A-3974-4CDF-93B5-D184C45DC40EQ37379456-15B49619-9B83-4F2E-9DCC-1A54DFC44F64Q37398135-A08799D7-9548-4A27-9F34-69A7A8A45AA8
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
NMDA receptor and schizophrenia: a brief history.
@en
NMDA receptor and schizophrenia: a brief history.
@nl
type
label
NMDA receptor and schizophrenia: a brief history.
@en
NMDA receptor and schizophrenia: a brief history.
@nl
prefLabel
NMDA receptor and schizophrenia: a brief history.
@en
NMDA receptor and schizophrenia: a brief history.
@nl
P2860
P356
P1476
NMDA receptor and schizophrenia: a brief history.
@en
P2093
Joseph T Coyle
P2860
P304
P356
10.1093/SCHBUL/SBS076
P407
P577
2012-09-01T00:00:00Z